Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 134 entries
Sorted by: Best Match Show Resources per page
[Physician as a team-member].

Ugeskrift for laeger

Helgason T.
PMID: 5491828
Ugeskr Laeger. 1970;26:2469-71.

No abstract available.

Cite
Helgason T. Laegen som team-medlem. [Physician as a team-member]. Ugeskr Laeger. 1970;26:2469-71
Helgason, T. (1970). Laegen som team-medlem. [Physician as a team-member]. Ugeskrift for laeger, 262469-71.
Helgason, T. "Laegen som team-medlem." [Physician as a team-member]. Ugeskrift for laeger vol. 26 (1970): 2469-71.
Helgason T. Laegen som team-medlem. [Physician as a team-member]. Ugeskr Laeger. 1970;26:2469-71. Danish. PMID: 5491828.
Copy Download .nbib Format: NLM
Feasibility Study of a Novel Electrode Concept for a Neuroprosthesis for Augmentation of Impaired Finger Functions.

European journal of translational myology

Hugosdóttir R, Jónasson SÞ, Sigþórsson H, Helgason Þ.
PMID: 26913139
Eur J Transl Myol. 2014 Sep 15;24(3):4671. doi: 10.4081/ejtm.2014.4671. eCollection 2014 Sep 23.

The project "Finger Rehabilitation" aims to design a neuroprosthesis with integrated electronics. The neuroprosthesis should enable spinal cord injured people, with injury at cervical vertebrae level, to increase finger mobility and activity with the use of functional electrical stimulation....

Cite
Hugosdóttir R, Jónasson SÞ, Sigþórsson H, et al. Feasibility Study of a Novel Electrode Concept for a Neuroprosthesis for Augmentation of Impaired Finger Functions. Eur J Transl Myol. 2014;24(3):4671doi: 10.4081/ejtm.2014.4671.
Hugosdóttir, R., Jónasson, S. �. �., Sigþórsson, H., & Helgason, �. �. (2014). Feasibility Study of a Novel Electrode Concept for a Neuroprosthesis for Augmentation of Impaired Finger Functions. European journal of translational myology, 24(3), 4671. https://doi.org/10.4081/ejtm.2014.4671
Hugosdóttir, Rósa, et al. "Feasibility Study of a Novel Electrode Concept for a Neuroprosthesis for Augmentation of Impaired Finger Functions." European journal of translational myology vol. 24,3 (2014): 4671. doi: https://doi.org/10.4081/ejtm.2014.4671
Hugosdóttir R, Jónasson SÞ, Sigþórsson H, Helgason Þ. Feasibility Study of a Novel Electrode Concept for a Neuroprosthesis for Augmentation of Impaired Finger Functions. Eur J Transl Myol. 2014 Sep 15;24(3):4671. doi: 10.4081/ejtm.2014.4671. eCollection 2014 Sep 23. PMID: 26913139; PMCID: PMC4756741.
Copy Download .nbib Format: NLM
The fuzzy cube and causal efficacy: representation of concomitant mechanisms in stroke.

Neural networks : the official journal of the International Neural Network Society

Jobe TH, Helgason CM.
PMID: 12662829
Neural Netw. 1998 Apr;11(3):549-555. doi: 10.1016/s0893-6080(97)00149-4.

Twentieth century medical science has embraced nineteenth century Boolean probability theory based upon two-valued Aristotelian logic. With the later addition of bit-based, von Neumann structured computational architectures, an epistemology based on randomness has led to a bivalent epidemiological methodology...

Cite
Jobe TH, Helgason CM. The fuzzy cube and causal efficacy: representation of concomitant mechanisms in stroke. Neural Netw. 1998;11(3):549-555doi: 10.1016/s0893-6080(97)00149-4.
Jobe, T. H., & Helgason, C. M. (1998). The fuzzy cube and causal efficacy: representation of concomitant mechanisms in stroke. Neural networks : the official journal of the International Neural Network Society, 11(3), 549-555. https://doi.org/10.1016/s0893-6080(97)00149-4
Jobe, Thomas H., and Helgason, Cathy M.. "The fuzzy cube and causal efficacy: representation of concomitant mechanisms in stroke." Neural networks : the official journal of the International Neural Network Society vol. 11,3 (1998): 549-555. doi: https://doi.org/10.1016/s0893-6080(97)00149-4
Jobe TH, Helgason CM. The fuzzy cube and causal efficacy: representation of concomitant mechanisms in stroke. Neural Netw. 1998 Apr;11(3):549-555. doi: 10.1016/s0893-6080(97)00149-4. PMID: 12662829.
Copy Download .nbib Format: NLM
[Use of warfarin anticoagulation in patients with atrial fibrillation in Iceland.].

Laeknabladid

Guðmundsdóttir IJ, Helgason KO, Sigurðsson EL, Arnar DO.
PMID: 16940645
Laeknabladid. 2002 Apr;88(4):299-303.

OBJECTIVE: Despite convincing evidence that warfarin anticoagulation reduces the risk of thromboembolism in patients with atrial fibrillation, recent data suggests that this therapy may be underutilized. Some patients are at higher risk than others and known risk factors for...

Cite
Guðmundsdóttir IJ, Helgason KO, Sigurðsson EL, et al. [Use of warfarin anticoagulation in patients with atrial fibrillation in Iceland.]. Laeknabladid. 2002;88(4):299-303
Guðmundsdóttir, I. J., Helgason, K. O., Sigurðsson, E. L., & Arnar, D. O. (2002). [Use of warfarin anticoagulation in patients with atrial fibrillation in Iceland.]. Laeknabladid, 88(4), 299-303.
Guðmundsdóttir, Ingibjœrg J, et al. "[Use of warfarin anticoagulation in patients with atrial fibrillation in Iceland.]." Laeknabladid vol. 88,4 (2002): 299-303.
Guðmundsdóttir IJ, Helgason KO, Sigurðsson EL, Arnar DO. [Use of warfarin anticoagulation in patients with atrial fibrillation in Iceland.]. Laeknabladid. 2002 Apr;88(4):299-303. Icelandic. PMID: 16940645.
Copy Download .nbib Format: NLM
Fuzzy logic and continuous cellular automata in warfarin dosing of stroke patients.

Current treatment options in cardiovascular medicine

Helgason CM, Jobe TH.
PMID: 16004852
Curr Treat Options Cardiovasc Med. 2005 Jul;7(3):211-8. doi: 10.1007/s11936-005-0049-4.

"Evidence-based" recommendations for warfarin prescription in patients with history of ischemic stroke limit its use to prevention of stroke due to atrial fibrillation. Warfarin is also prescribed by the authors to prevent thrombosis in stroke patients with thrombophilia and...

Cite
Helgason CM, Jobe TH. Fuzzy logic and continuous cellular automata in warfarin dosing of stroke patients. Curr Treat Options Cardiovasc Med. 2005;7(3):211-8doi: 10.1007/s11936-005-0049-4.
Helgason, C. M., & Jobe, T. H. (2005). Fuzzy logic and continuous cellular automata in warfarin dosing of stroke patients. Current treatment options in cardiovascular medicine, 7(3), 211-8. https://doi.org/10.1007/s11936-005-0049-4
Helgason, Cathy M, and Jobe, Thomas H. "Fuzzy logic and continuous cellular automata in warfarin dosing of stroke patients." Current treatment options in cardiovascular medicine vol. 7,3 (2005): 211-8. doi: https://doi.org/10.1007/s11936-005-0049-4
Helgason CM, Jobe TH. Fuzzy logic and continuous cellular automata in warfarin dosing of stroke patients. Curr Treat Options Cardiovasc Med. 2005 Jul;7(3):211-8. doi: 10.1007/s11936-005-0049-4. PMID: 16004852.
Copy Download .nbib Format: NLM
[Health-related quality of life.].

Laeknabladid

Helgason T, Bjornsson JK, Tomasson K, Ingimarsson S.
PMID: 19679907
Laeknabladid. 1997 Jul;83(7):492-502.

INTRODUCTION: With increasing technology in medicine and possibilities to extend life, interest for studying health-related quality of life, i.e. the subjective well-being of patients against the background of their diseases, accidents or treatment, has increased. The purpose of this...

Cite
Helgason T, Bjornsson JK, Tomasson K, et al. [Health-related quality of life.]. Laeknabladid. 1997;83(7):492-502
Helgason, T., Bjornsson, J. K., Tomasson, K., & Ingimarsson, S. (1997). [Health-related quality of life.]. Laeknabladid, 83(7), 492-502.
Helgason, T, et al. "[Health-related quality of life.]." Laeknabladid vol. 83,7 (1997): 492-502.
Helgason T, Bjornsson JK, Tomasson K, Ingimarsson S. [Health-related quality of life.]. Laeknabladid. 1997 Jul;83(7):492-502. Icelandic. PMID: 19679907.
Copy Download .nbib Format: NLM
[Health-related quality of life among Icelanders.].

Laeknabladid

Helgason T, Bjœrnsson JK, Tómasson K, Grétarsdóttir E.
PMID: 17018925
Laeknabladid. 2000 Apr;86(4):251-7.

OBJECTIVE: To study health-related quality of life (HRQL) among adults in Iceland with a generic Icelandic instrument, IQL (Icelandic Quality of Life), if it is the same among men and women, and if it changes by increasing age. Furthermore,...

Cite
Helgason T, Bjœrnsson JK, Tómasson K, et al. [Health-related quality of life among Icelanders.]. Laeknabladid. 2000;86(4):251-7
Helgason, T., Bjœrnsson, J. K., Tómasson, K., & Grétarsdóttir, E. (2000). [Health-related quality of life among Icelanders.]. Laeknabladid, 86(4), 251-7.
Helgason, T, et al. "[Health-related quality of life among Icelanders.]." Laeknabladid vol. 86,4 (2000): 251-7.
Helgason T, Bjœrnsson JK, Tómasson K, Grétarsdóttir E. [Health-related quality of life among Icelanders.]. Laeknabladid. 2000 Apr;86(4):251-7. Icelandic. PMID: 17018925.
Copy Download .nbib Format: NLM
[Validation of an Icelandic version of the Geriatric Depression Scale (GDS).].

Laeknabladid

Helgason T, Bjœrnsson JK, Tómasson K, Grétarsdóttir E, Jónsson H, Zoega T, Harðarson T, Einarsson GV.
PMID: 17018933
Laeknabladid. 2000 Jun;86(6):422-8.

OBJECTIVE: Health-related quality of life (HRQL) is increasingly used to estimate needs for medical treatment, to evaluate its outcome and quality of care. The aim of this study was to compare the HRQL of several diagnostic groups before and...

Cite
Helgason T, Bjœrnsson JK, Tómasson K, et al. [Validation of an Icelandic version of the Geriatric Depression Scale (GDS).]. Laeknabladid. 2000;86(6):422-8
Helgason, T., Bjœrnsson, J. K., Tómasson, K., Grétarsdóttir, E., Jónsson, H., Zoega, T., Harðarson, T., & Einarsson, G. V. (2000). [Validation of an Icelandic version of the Geriatric Depression Scale (GDS).]. Laeknabladid, 86(6), 422-8.
Helgason, T, et al. "[Validation of an Icelandic version of the Geriatric Depression Scale (GDS).]." Laeknabladid vol. 86,6 (2000): 422-8.
Helgason T, Bjœrnsson JK, Tómasson K, Grétarsdóttir E, Jónsson H, Zoega T, Harðarson T, Einarsson GV. [Validation of an Icelandic version of the Geriatric Depression Scale (GDS).]. Laeknabladid. 2000 Jun;86(6):422-8. Icelandic. PMID: 17018933.
Copy Download .nbib Format: NLM
Serum proteomics and disease-specific biomarkers of patients with advanced gastric cancer.

Oncology letters

Helgason HH, Engwegen JY, Zapatka M, Cats A, Boot H, Beijnen JH, Schellens JH.
PMID: 22966303
Oncol Lett. 2010 Mar;1(2):327-333. doi: 10.3892/ol_00000058. Epub 2010 Mar 01.

Gastric cancer is a commonly diagnosed solid tumor which is associated with a dismal prognosis making early diagnosis essential. Thus, this study aimed to identify novel biomarkers in gastric cancer. Serum of patients with advanced gastric cancer was collected...

Cite
Helgason HH, Engwegen JY, Zapatka M, et al. Serum proteomics and disease-specific biomarkers of patients with advanced gastric cancer. Oncol Lett. 2010;1(2):327-333doi: 10.3892/ol_00000058.
Helgason, H. H., Engwegen, J. Y., Zapatka, M., Cats, A., Boot, H., Beijnen, J. H., & Schellens, J. H. (2010). Serum proteomics and disease-specific biomarkers of patients with advanced gastric cancer. Oncology letters, 1(2), 327-333. https://doi.org/10.3892/ol_00000058
Helgason, Helgi H, et al. "Serum proteomics and disease-specific biomarkers of patients with advanced gastric cancer." Oncology letters vol. 1,2 (2010): 327-333. doi: https://doi.org/10.3892/ol_00000058
Helgason HH, Engwegen JY, Zapatka M, Cats A, Boot H, Beijnen JH, Schellens JH. Serum proteomics and disease-specific biomarkers of patients with advanced gastric cancer. Oncol Lett. 2010 Mar;1(2):327-333. doi: 10.3892/ol_00000058. Epub 2010 Mar 01. PMID: 22966303; PMCID: PMC3436443.
Copy Download .nbib Format: NLM
P/Q and N-type Voltage-gated Calcium Channel Binding Antibodies Associated with Paraneoplastic Chorea and Mixed Invasive Ductal and Lobular Carcinoma of the Breasts in an Elderly Patient.

Cureus

Chang K, Lwanga A, Kaur T, Helgason C.
PMID: 30338173
Cureus. 2018 Aug 04;10(8):e3097. doi: 10.7759/cureus.3097.

Paraneoplastic neurologic syndromes are a group of immune-mediated, cancer-associated disorders affecting the nervous system. While these syndromes are not understood fully, they are reportedly caused by an immune response against common antigens expressed by the cancer and nervous system....

Cite
Chang K, Lwanga A, Kaur T, et al. P/Q and N-type Voltage-gated Calcium Channel Binding Antibodies Associated with Paraneoplastic Chorea and Mixed Invasive Ductal and Lobular Carcinoma of the Breasts in an Elderly Patient. Cureus. 2018;10(8):e3097doi: 10.7759/cureus.3097.
Chang, K., Lwanga, A., Kaur, T., & Helgason, C. (2018). P/Q and N-type Voltage-gated Calcium Channel Binding Antibodies Associated with Paraneoplastic Chorea and Mixed Invasive Ductal and Lobular Carcinoma of the Breasts in an Elderly Patient. Cureus, 10(8), e3097. https://doi.org/10.7759/cureus.3097
Chang, Kevin, et al. "P/Q and N-type Voltage-gated Calcium Channel Binding Antibodies Associated with Paraneoplastic Chorea and Mixed Invasive Ductal and Lobular Carcinoma of the Breasts in an Elderly Patient." Cureus vol. 10,8 (2018): e3097. doi: https://doi.org/10.7759/cureus.3097
Chang K, Lwanga A, Kaur T, Helgason C. P/Q and N-type Voltage-gated Calcium Channel Binding Antibodies Associated with Paraneoplastic Chorea and Mixed Invasive Ductal and Lobular Carcinoma of the Breasts in an Elderly Patient. Cureus. 2018 Aug 04;10(8):e3097. doi: 10.7759/cureus.3097. PMID: 30338173; PMCID: PMC6175266.
Copy Download .nbib Format: NLM
A feasibility study of neoadjuvant talazoparib for operable breast cancer patients with a germline .

NPJ breast cancer

Litton JK, Scoggins M, Ramirez DL, Murthy RK, Whitman GJ, Hess KR, Adrada BE, Moulder SL, Barcenas CH, Valero V, Gomez JS, Mittendorf EA, Thompson A, Helgason T, Mills GB, Piwnica-Worms H, Arun BK.
PMID: 29238749
NPJ Breast Cancer. 2017 Dec 06;3:49. doi: 10.1038/s41523-017-0052-4. eCollection 2017.

This study was undertaken to determine the feasibility of enrolling breast cancer patients on a single-agent-targeted therapy trial before neoadjuvant chemotherapy. Specifically, we evaluated talazoparib in patients harboring a deleterious BRCA mutation (BRCA+). Patients with a germline BRCA mutation...

Cite
Litton JK, Scoggins M, Ramirez DL, et al. A feasibility study of neoadjuvant talazoparib for operable breast cancer patients with a germline . NPJ Breast Cancer. 2017;3:49doi: 10.1038/s41523-017-0052-4.
Litton, J. K., Scoggins, M., Ramirez, D. L., Murthy, R. K., Whitman, G. J., Hess, K. R., Adrada, B. E., Moulder, S. L., Barcenas, C. H., Valero, V., Gomez, J. S., Mittendorf, E. A., Thompson, A., Helgason, T., Mills, G. B., Piwnica-Worms, H., & Arun, B. K. (2017). A feasibility study of neoadjuvant talazoparib for operable breast cancer patients with a germline . NPJ breast cancer, 349. https://doi.org/10.1038/s41523-017-0052-4
Litton, J K, et al. "A feasibility study of neoadjuvant talazoparib for operable breast cancer patients with a germline ." NPJ breast cancer vol. 3 (2017): 49. doi: https://doi.org/10.1038/s41523-017-0052-4
Litton JK, Scoggins M, Ramirez DL, Murthy RK, Whitman GJ, Hess KR, Adrada BE, Moulder SL, Barcenas CH, Valero V, Gomez JS, Mittendorf EA, Thompson A, Helgason T, Mills GB, Piwnica-Worms H, Arun BK. A feasibility study of neoadjuvant talazoparib for operable breast cancer patients with a germline . NPJ Breast Cancer. 2017 Dec 06;3:49. doi: 10.1038/s41523-017-0052-4. eCollection 2017. PMID: 29238749; PMCID: PMC5719044.
Copy Download .nbib Format: NLM
Auto-Commentary on: "Targeting mitochondrial oxidative phosphorylation eradicates therapy-resistant chronic myeloid leukemia stem cells".

Molecular & cellular oncology

de Beauchamp L, Baquero P, Kuntz EM, Gottlieb E, Helgason GV.
PMID: 29404396
Mol Cell Oncol. 2017 Dec 18;5(1):e1403532. doi: 10.1080/23723556.2017.1403532. eCollection 2018.

We have recently uncovered an abnormal increase in mitochondrial oxidative metabolism in therapy-resistant chronic myeloid leukaemia stem cells (LSCs). By simultaneously disrupting mitochondrial respiration and inhibiting BCR-ABL kinase activity using the antibiotic tigecycline and imatinib respectively, we effectively eradicated...

Cite
de Beauchamp L, Baquero P, Kuntz EM, et al. Auto-Commentary on: "Targeting mitochondrial oxidative phosphorylation eradicates therapy-resistant chronic myeloid leukemia stem cells". Mol Cell Oncol. 2017;5(1):e1403532doi: 10.1080/23723556.2017.1403532.
de Beauchamp, L., Baquero, P., Kuntz, E. M., Gottlieb, E., & Helgason, G. V. (2018). Auto-Commentary on: "Targeting mitochondrial oxidative phosphorylation eradicates therapy-resistant chronic myeloid leukemia stem cells". Molecular & cellular oncology, 5(1), e1403532. https://doi.org/10.1080/23723556.2017.1403532
de Beauchamp, Lucie, et al. "Auto-Commentary on: "Targeting mitochondrial oxidative phosphorylation eradicates therapy-resistant chronic myeloid leukemia stem cells"." Molecular & cellular oncology vol. 5,1 (2018): e1403532. doi: https://doi.org/10.1080/23723556.2017.1403532
de Beauchamp L, Baquero P, Kuntz EM, Gottlieb E, Helgason GV. Auto-Commentary on: "Targeting mitochondrial oxidative phosphorylation eradicates therapy-resistant chronic myeloid leukemia stem cells". Mol Cell Oncol. 2017 Dec 18;5(1):e1403532. doi: 10.1080/23723556.2017.1403532. eCollection 2018. PMID: 29404396; PMCID: PMC5791851.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 134 entries